Cargando…
Obesity, metabolic syndrome and diabetic retinopathy: Beyond hyperglycemia
Diabetic retinopathy (DR) is the most feared ocular manifestation of diabetes. DR is characterized by progressive retinal damage that may eventually result in blindness. Clinically, this blindness is caused by progressive damage to the retinal microvasculature, which leads to ischemia, retinal swell...
Autores principales: | Mbata, Osinakachukwu, Abo El-Magd, Nada Fawzy, El-Remessy, Azza Bahram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507828/ https://www.ncbi.nlm.nih.gov/pubmed/28751954 http://dx.doi.org/10.4239/wjd.v8.i7.317 |
Ejemplares similares
-
Imbalance of the Nerve Growth Factor and Its Precursor: Implication in Diabetic Retinopathy
por: Mohamed, Riyaz, et al.
Publicado: (2015) -
Molecular Mechanisms of Diabetic Retinopathy: Potential Therapeutic Targets
por: Coucha, Maha, et al.
Publicado: (2015) -
Deletion of p75(NTR) prevents vaso-obliteration and retinal neovascularization via activation of Trk- A receptor in ischemic retinopathy model
por: Elshaer, Sally L., et al.
Publicado: (2018) -
Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far
por: Whitmire, Will, et al.
Publicado: (2011) -
Deletion of Thioredoxin Interacting Protein (TXNIP) Augments Hyperoxia-Induced Vaso-Obliteration in a Mouse Model of Oxygen Induced-Retinopathy
por: Abdelsaid, Mohammed A., et al.
Publicado: (2014)